Norwich COVID-19 testing initiative pilot: evaluating the feasibility of asymptomatic testing on a university campus.


Journal

Journal of public health (Oxford, England)
ISSN: 1741-3850
Titre abrégé: J Public Health (Oxf)
Pays: England
ID NLM: 101188638

Informations de publication

Date de publication:
12 04 2021
Historique:
received: 01 10 2020
revised: 01 10 2020
accepted: 07 10 2020
pubmed: 31 10 2020
medline: 23 4 2021
entrez: 30 10 2020
Statut: ppublish

Résumé

There is a high prevalence of COVID-19 in university-age students, who are returning to campuses. There is little evidence regarding the feasibility of universal, asymptomatic testing to help control outbreaks in this population. This study aimed to pilot mass COVID-19 testing on a university research park, to assess the feasibility and acceptability of scaling up testing to all staff and students. This was a cross-sectional feasibility study on a university research park in the East of England. All staff and students (5625) were eligible to participate. All participants were offered four PCR swabs, which they self-administered over two weeks. Outcome measures included uptake, drop-out rate, positivity rates, participant acceptability measures, laboratory processing measures, data collection and management measures. 798 (76%) of 1053 who registered provided at least one swab; 687 (86%) provided all four; 792 (99%) of 798 who submitted at least one swab had all negative results and 6 participants had one inconclusive result. There were no positive results. 458 (57%) of 798 participants responded to a post-testing survey, demonstrating a mean acceptability score of 4.51/5, with five being the most positive. Repeated self-testing for COVID-19 using PCR is feasible and acceptable to a university population.

Sections du résumé

BACKGROUND
There is a high prevalence of COVID-19 in university-age students, who are returning to campuses. There is little evidence regarding the feasibility of universal, asymptomatic testing to help control outbreaks in this population. This study aimed to pilot mass COVID-19 testing on a university research park, to assess the feasibility and acceptability of scaling up testing to all staff and students.
METHODS
This was a cross-sectional feasibility study on a university research park in the East of England. All staff and students (5625) were eligible to participate. All participants were offered four PCR swabs, which they self-administered over two weeks. Outcome measures included uptake, drop-out rate, positivity rates, participant acceptability measures, laboratory processing measures, data collection and management measures.
RESULTS
798 (76%) of 1053 who registered provided at least one swab; 687 (86%) provided all four; 792 (99%) of 798 who submitted at least one swab had all negative results and 6 participants had one inconclusive result. There were no positive results. 458 (57%) of 798 participants responded to a post-testing survey, demonstrating a mean acceptability score of 4.51/5, with five being the most positive.
CONCLUSIONS
Repeated self-testing for COVID-19 using PCR is feasible and acceptable to a university population.

Identifiants

pubmed: 33124664
pii: 5942928
doi: 10.1093/pubmed/fdaa194
pmc: PMC7665602
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

82-88

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of Faculty of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

T Berger Gillam (TB)

Faculty of Medicine and Health Sciences, University of East Anglia, Norwich NR4 7TJ, UK.

J Cole (J)

Faculty of Medicine and Health Sciences, University of East Anglia, Norwich NR4 7TJ, UK.

K Gharbi (K)

Genomics Pipelines, Earlham Institute, Norwich, NR4 7UZ, UK.

E Angiolini (E)

Scientific Training and Education, Earlham Institute, Norwich NR4 7UZ, UK.

T Barker (T)

Genomics Pipelines, Earlham Institute, Norwich, NR4 7UZ, UK.

P Bickerton (P)

Communications, Earlham Institute, Norwich NR4 7UZ, UK.

T Brabbs (T)

Genomics Pipelines, Earlham Institute, Norwich, NR4 7UZ, UK.

J Chin (J)

School of Computing Sciences, University of East Anglia, Norwich NR4 7TJ, UK.

E Coen (E)

John Innes Centre, Norwich NR4 7UH, UK.

S Cossey (S)

Earlham Institute, Norwich NR4 7UZ, UK.

R Davey (R)

Earlham Institute, Norwich NR4 7UZ, UK.

R Davidson (R)

Faculty of Medicine and Health Sciences, University of East Anglia, Norwich NR4 7TJ, UK.

A Durrant (A)

Genomics Pipelines, Earlham Institute, Norwich, NR4 7UZ, UK.

D Edwards (D)

Faculty of Medicine and Health Sciences, University of East Anglia, Norwich NR4 7TJ, UK.

N Hall (N)

Earlham Institute, Norwich NR4 7UZ, UK.
UEA Biosciences, University of East Anglia, Norwich NR4 7TJ, UK.

S Henderson (S)

Genomics Pipelines, Earlham Institute, Norwich, NR4 7UZ, UK.

M Hitchcock (M)

UEA Health and Social Care Partners, University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, UK.

N Irish (N)

Genomics Pipelines, Earlham Institute, Norwich, NR4 7UZ, UK.

J Lipscombe (J)

Genomics Pipelines, Earlham Institute, Norwich, NR4 7UZ, UK.

G Jones (G)

Communications, Earlham Institute, Norwich NR4 7UZ, UK.

G Parr (G)

School of Computing Sciences, University of East Anglia, Norwich NR4 7TJ, UK.

S Rushworth (S)

Faculty of Medicine and Health Sciences, University of East Anglia, Norwich NR4 7TJ, UK.

N Shearer (N)

Genomics Pipelines, Earlham Institute, Norwich, NR4 7UZ, UK.

R Smith (R)

Faculty of Medicine and Health Sciences, University of East Anglia, Norwich NR4 7TJ, UK.

N Steel (N)

Faculty of Medicine and Health Sciences, University of East Anglia, Norwich NR4 7TJ, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH